Cargando…

Scalable, semi-automated fluorescence reduction neutralization assay for qualitative assessment of Ebola virus-neutralizing antibodies in human clinical samples

Antibody titers against a viral pathogen are typically measured using an antigen binding assay, such as an enzyme-linked immunosorbent assay (ELISA), which only measures the ability of antibodies to identify a viral antigen of interest. Neutralization assays measure the presence of virus-neutralizin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Postnikova, Elena N., Pettitt, James, Van Ryn, Collin J., Holbrook, Michael R., Bollinger, Laura, Yú, Shuǐqìng, Caì, Yíngyún, Liang, Janie, Sneller, Michael C., Jahrling, Peter B., Hensley, Lisa E., Kuhn, Jens H., Fallah, Mosoka P., Bennett, Richard S., Reilly, Cavan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6711594/ https://www.ncbi.nlm.nih.gov/pubmed/31454374 http://dx.doi.org/10.1371/journal.pone.0221407

Ejemplares similares

Scalable, Micro-Neutralization Assay for Assessment of SARS-CoV-2 (COVID-19) Virus-Neutralizing Antibodies in Human Clinical Samples
por: Bennett, Richard S., et al.
Publicado: (2021)

Scalable, Micro-Neutralization Assay for Qualitative Assessment of SARS-CoV-2 (COVID-19) Virus-Neutralizing Antibodies in Human Clinical Samples
por: Bennett, Richard S., et al.
Publicado: (2021)

The impact of the 2014 Ebola epidemic on HIV disease burden and outcomes in Liberia West Africa
por: Moses, Soka J., et al.
Publicado: (2021)

Increased Likelihood of Detecting Ebola Virus RNA in Semen by Using Sample Pelleting
por: Bozman, Courtney M., et al.
Publicado: (2021)

Clinical sequelae among individuals with pauci-symptomatic or asymptomatic Ebola virus infection and unrecognised Ebola virus disease in Liberia: a longitudinal cohort study
por: Kelly, J Daniel, et al.
Publicado: (2022)

Recombinant Lassa Virus Expressing Green Fluorescent Protein as a Tool for High-Throughput Drug Screens and Neutralizing Antibody Assays
por: Caì, Yíngyún, et al.
Publicado: (2018)

Ebola virus disease-related stigma among survivors declined in Liberia over an 18-month, post-outbreak period: An observational cohort study
por: Kelly, J. Daniel, et al.
Publicado: (2019)

Use of the Filovirus Animal Non-Clinical Group (FANG) Ebola virus immuno-assay requires fewer study participants to power a study than the Alpha Diagnostic International assay
por: Logue, James, et al.
Publicado: (2018)

A Novel Ebola Virus VP40 Matrix Protein-Based Screening for Identification of Novel Candidate Medical Countermeasures
por: Bennett, Ryan P., et al.
Publicado: (2020)

CD26/DPP4 Cell-Surface Expression in Bat Cells Correlates with Bat Cell Susceptibility to Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Infection and Evolution of Persistent Infection
por: Caì, Yíngyún, et al.
Publicado: (2014)

An immunotoxin targeting Ebola virus glycoprotein inhibits Ebola virus production from infected cells
por: Cai, Yingyun, et al.
Publicado: (2021)

Neutralizing Antibody Fails to Impact the Course of Ebola Virus Infection in Monkeys
por: Oswald, Wendelien B, et al.
Publicado: (2007)

Ebola Virus Neutralizing Antibodies Detectable in Survivors of theYambuku, Zaire Outbreak 40 Years after Infection
por: Rimoin, Anne W, et al.
Publicado: (2018)

Long-Term Decrease in Intraocular Pressure in Survivors of Ebola Virus Disease in the Partnership for Research on Vaccines and Infectious Diseases in Liberia (PREVAIL) III Study
por: Mudalegundi, Shwetha, et al.
Publicado: (2022)

Overcoming distrust to deliver universal health coverage: lessons from Ebola
por: Woskie, Liana R, et al.
Publicado: (2019)

Characterization of Ebola Virus–Associated Eye Disease
por: Eghrari, Allen O., et al.
Publicado: (2021)

A VLP-based vaccine provides complete protection against Nipah virus challenge following multiple-dose or single-dose vaccination schedules in a hamster model
por: Walpita, Pramila, et al.
Publicado: (2017)

Peripheral immune response in the African green monkey model following Nipah-Malaysia virus exposure by intermediate-size particle aerosol
por: Lara, Abigail, et al.
Publicado: (2019)

Repurposing Pyramax®, quinacrine and tilorone as treatments for Ebola virus disease
por: Lane, Thomas R., et al.
Publicado: (2020)

Efficacy and Safety Outcomes of Cataract Surgery in Survivors of Ebola Virus Disease: 12-Month Results From the PREVAIL VII Study
por: Eghrari, Allen O., et al.
Publicado: (2021)

Lack of Effect of Lamivudine on Ebola Virus Replication
por: Hensley, Lisa E., et al.
Publicado: (2015)

Quantifying Poverty as a Driver of Ebola Transmission
por: Fallah, Mosoka P., et al.
Publicado: (2015)

In Vivo Activity of Amodiaquine against Ebola Virus Infection
por: DeWald, Lisa Evans, et al.
Publicado: (2019)

Inactivation and safety testing of Middle East Respiratory Syndrome Coronavirus
por: Kumar, Mia, et al.
Publicado: (2015)

Testing therapeutics in cell-based assays: Factors that influence the apparent potency of drugs
por: Postnikova, Elena, et al.
Publicado: (2018)

Ebola Virus Localization in the Macaque Reproductive Tract during Acute Ebola Virus Disease
por: Perry, Donna L., et al.
Publicado: (2018)

Inhibition of Ebola Virus by a Molecularly Engineered Banana Lectin
por: Covés-Datson, Evelyn M., et al.
Publicado: (2019)

Potent neutralizing monoclonal antibodies against Ebola virus infection
por: Zhang, Qi, et al.
Publicado: (2016)

Neutralization of MERS coronavirus through a scalable nanoparticle vaccine
por: Mohsen, Mona O., et al.
Publicado: (2021)

Antibody-mediated neutralization of Ebola virus can occur by two distinct mechanisms
por: Shedlock, Devon J., et al.
Publicado: (2010)

Complete mapping of viral escape from neutralizing antibodies
por: Doud, Michael B., et al.
Publicado: (2017)

Development and Characterization of a cDNA-Launch Recombinant Simian Hemorrhagic Fever Virus Expressing Enhanced Green Fluorescent Protein: ORF 2b’ Is Not Required for In Vitro Virus Replication
por: Cai, Yingyun, et al.
Publicado: (2021)

Psychological Distress among Ebola Survivors Discharged from an Ebola Treatment Unit in Monrovia, Liberia – A Qualitative Study
por: Rabelo, Ionara, et al.
Publicado: (2016)

Ebola Virus Neutralizing Antibodies in Dogs from Sierra Leone, 2017
por: Fischer, Kerstin, et al.
Publicado: (2020)

Formulation, Stability, Pharmacokinetic, and Modeling Studies for Tests of Synergistic Combinations of Orally Available Approved Drugs against Ebola Virus In Vivo
por: Finch, Courtney L., et al.
Publicado: (2021)

Sangivamycin is highly effective against SARS-CoV-2 in vitro and has favorable drug properties
por: Bennett, Ryan P., et al.
Publicado: (2022)

Contextualizing mobility during the Ebola epidemic in Liberia
por: Fallah, Mosoka, et al.
Publicado: (2022)

Genome Sequence of Bivens Arm Virus, a Tibrovirus Belonging to the Species Tibrogargan virus (Mononegavirales: Rhabdoviridae)
por: Lauck, Michael, et al.
Publicado: (2015)

Multivalent viral particles elicit safe and efficient immunoprotection against Nipah Hendra and Ebola viruses
por: Ithinji, Duncan G., et al.
Publicado: (2022)

Reduced evolutionary rate in reemerged Ebola virus transmission chains
por: Blackley, David J., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_gh6s7ket8ert7p1sgjsnih4kee